345,441 Shares in Teladoc Health, Inc. (NYSE:TDOC) Purchased by Susquehanna Fundamental Investments LLC

Susquehanna Fundamental Investments LLC purchased a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 345,441 shares of the health services provider's stock, valued at approximately $3,140,000. Susquehanna Fundamental Investments LLC owned approximately 0.20% of Teladoc Health as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of TDOC. Whipplewood Advisors LLC purchased a new stake in Teladoc Health during the fourth quarter valued at about $29,000. Versant Capital Management Inc raised its holdings in shares of Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock valued at $29,000 after buying an additional 2,441 shares in the last quarter. Lindbrook Capital LLC lifted its position in Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after buying an additional 1,612 shares during the last quarter. Sterling Capital Management LLC boosted its stake in Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after buying an additional 4,101 shares in the last quarter. Finally, Pilgrim Partners Asia Pte Ltd bought a new position in shares of Teladoc Health during the 4th quarter valued at $60,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Analyst Upgrades and Downgrades

TDOC has been the topic of a number of recent research reports. The Goldman Sachs Group reduced their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a research note on Thursday. Oppenheimer decreased their price target on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research note on Friday, January 24th. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a research report on Thursday. Evercore ISI cut their target price on shares of Teladoc Health from $8.00 to $7.00 and set an "in-line" rating on the stock in a report on Thursday. Finally, Jefferies Financial Group lowered their price target on shares of Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a report on Monday, April 21st. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $9.81.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the transaction, the insider now directly owns 64,308 shares of the company's stock, valued at approximately $541,473.36. The trade was a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.58% of the stock is owned by company insiders.

Teladoc Health Stock Up 1.1 %

Shares of NYSE:TDOC traded up $0.08 during midday trading on Friday, reaching $7.07. The company's stock had a trading volume of 6,366,764 shares, compared to its average volume of 6,258,734. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm has a 50 day moving average of $8.02 and a 200-day moving average of $9.49. The firm has a market capitalization of $1.24 billion, a P/E ratio of -1.23 and a beta of 1.73. Teladoc Health, Inc. has a 12-month low of $6.35 and a 12-month high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. On average, research analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.